Source: http://www.google.com/patents/US8012143?dq=5572193
Timestamp: 2016-12-07 21:19:43
Document Index: 583005700

Matched Legal Cases: ['art 60', 'art 60', 'art 60', 'art 60', 'art 60', 'art 60', 'art 60', 'art 60', 'art 60', 'art 60']

Patent US8012143 - Intrapericardial delivery tools and methods - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAn introducer sheath is disclosed herein. The sheath includes a tubular body. The tubular body has a proximal zone, an intermediate zone and a distal zone. The proximal zone is generally straight. The intermediate zone extends from a distal end of the proximal zone and curves in a first direction. The...http://www.google.com/patents/US8012143?utm_source=gb-gplus-sharePatent US8012143 - Intrapericardial delivery tools and methodsAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS8012143 B1Publication typeGrantApplication numberUS 11/609,751Publication dateSep 6, 2011Filing dateDec 12, 2006Priority dateDec 12, 2006Fee statusPaidPublication number11609751, 609751, US 8012143 B1, US 8012143B1, US-B1-8012143, US8012143 B1, US8012143B1InventorsGreg Kampa, Anna Barlow, Kevin L. Morgan, Michael Yang, Steven R. Conger, Stuart Rosenberg, Wenbo HouOriginal AssigneePacesetter, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (42), Non-Patent Citations (5), Referenced by (7), Classifications (12), Legal Events (3) External Links: USPTO, USPTO Assignment, EspacenetIntrapericardial delivery tools and methods
US 8012143 B1Abstract
An introducer sheath is disclosed herein. The sheath includes a tubular body. The tubular body has a proximal zone, an intermediate zone and a distal zone. The proximal zone is generally straight. The intermediate zone extends from a distal end of the proximal zone and curves in a first direction. The distal zone extends from a distal end of the intermediate zone and curves in a second direction different from the first direction.
1. An introducer sheath having a curved portion configured to generally match the curved epicardial surface of a heart, said sheath comprising a tubular body having a longitudinal axis extending there through, the tubular body including a proximal zone having a distal end, an intermediate zone having a distal end and a distal zone having a distal end defining an opening at the distal tip of the tubular body, wherein the proximal zone is generally straight along its entire length (LPZ), the intermediate zone extends from the distal end of the proximal zone and curves along its entire length (LIZ) in a first direction, and the distal zone extends from the distal end of the intermediate zone and curves along its entire length (LDZ) in a second direction different from the first direction, wherein the combined effect of the curves of the intermediate and distal zones results in the portion of the longitudinal axis extending through the distal tip of the tubular body being nearly parallel to the portion of the longitudinal axis extending through the proximal zone, wherein the length of the intermediate zone (LIZ) is less than the length of the distal zone (LDZ) and the length of the distal zone (LDZ) is less than the length of the proximal zone (LPZ), and wherein the intermediate zone and the distal zone define the curved portion and the curved portion is arranged with respect to the proximal zone so as to sweep about the heart upon rotation of the proximal zone about the longitudinal axis.
2. The sheath of claim 1, wherein the length of the intermediate zone (LIZ) is approximately 2.5 centimeters and the length of the distal zone (LDZ) is approximately 4.8 centimeters.
3. The sheath of claim 1, wherein the portion of the longitudinal distal extending through the distal tip end of the tubular body is anywhere from greater than zero degrees to approximately twenty degrees from being parallel to the portion of the longitudinal axis extending through the proximal zone.
4. The sheath of claim 1, wherein the proximal zone is more rigid than the entire intermediate zone and the entire intermediate zone is more rigid than the distal zone.
5. The sheath of claim 1, further comprising an atraumatic tip extending from the distal end of the distal zone and wherein the tip is less rigid than the distal zone.
6. The sheath of claim 1, further comprising an inflatable balloon coupled to the tubular body nearer a transition between the proximal and intermediate zones than the distal zone.
7. The sheath of claim 1, wherein the second direction is reversed with respect to the first direction.
8. The sheath of claim 1, wherein the length of the intermediate zone (LIZ) is between approximately two centimeters and approximately six centimeters.
9. The sheath of claim 1, wherein the length of the distal zone (LDZ) is between approximately two centimeters and approximately ten centimeters.
10. The sheath of claim 1 wherein the length of the proximal zone (LPZ) is between approximately eight centimeters and 18 centimeters.
11. The sheath of claim 1 wherein the length of the proximal zone (LPZ) is approximately ten centimeters.
12. The sheath of claim 1 wherein the portion of the longitudinal axis extending through the distal tip end of the tubular body is approximately ten degrees from being parallel to the portion of the longitudinal axis extending through the proximal zone.
13. The sheath of claim 1 wherein the distal end of the distal zone is offset from the distal end of the proximal zone a linear distance D of approximately 6.4 centimeters.
14. The sheath of claim 1 wherein the distal end of the distal zone is offset from the distal end of the proximal zone a linear distance D of between approximately five centimeters and approximately 14 centimeters.
15. An introducer sheath having a curved portion configured to generally match the curved epicardial surface of a heart, said sheath comprising a tubular body having a longitudinal axis extending there through, the tubular body including a proximal zone having a distal end, an intermediate zone having a distal end and a distal zone having a distal end defining an opening at the distal tip of the tubular body, wherein the proximal zone is generally straight along its entire length (LPZ), the intermediate zone extends from the distal end of the proximal zone and curves along its entire length over a radius (RIZ), in a first direction to define an angle of curvature (AIZ), and the distal zone extends from the distal end of the intermediate zone and curves along its entire length over a radius (RDZ) in a second direction different from the first direction to define an angle of curvature (ADZ), wherein the combined effect of the curves of the intermediate and distal zones results in the portion of the longitudinal axis extending through the distal tip of the tubular body being nearly parallel to the portion of the longitudinal axis extending through the proximal zone, wherein the angle of curvature of the intermediate zone (AIZ) is less than the angle of curvature of the distal zone (ADZ) and the length of the distal zone is less than the length of the proximal zone, and wherein the intermediate zone and the distal zone define the curved portion and the curved portion is arranged with respect to the proximal zone so as to sweep about the heart upon rotation of the proximal zone about the longitudinal axis.
16. The sheath of claim 15, wherein the angle of curvature of the intermediate zone (AIZ) is approximately 45 degrees and the angle of curvature of the distal zone (ADZ) is approximately 55 degrees.
17. The sheath of claim 15, wherein the angle of curvature of the intermediate zone (AIZ) is between approximately 30 degrees and approximately 60 degrees.
18. The sheath of claim 15, wherein the angle of curvature of the distal zone (ADZ) is between approximately 30 degrees and approximately 85 degrees.
19. The sheath of claim 15 wherein the portion of the longitudinal axis extending through the distal tip end of the tubular body is approximately ten degrees from being parallel to the portion of the longitudinal axis extending through the proximal zone.
20. The sheath of claim 15 wherein the intermediate zone curves over a radius (RIZ) of between approximately two centimeters and approximately five centimeters.
21. The sheath of claim 15 wherein the intermediate zone curves over a radius (RIZ) of approximately 2.8 centimeters.
22. The sheath of claim 15 wherein the distal zone curves over a radius (RDZ) of between approximately two centimeters and approximately eight centimeters.
23. The sheath of claim 15 wherein the distal zone curves over a radius (RDZ) of approximately 4.6 centimeters.
24. The sheath of claim 15 wherein:
the distal zone curves over a radius (RDZ) of between approximately two centimeters and approximately eight centimeters;
the intermediate zone curves over a radius (RIZ) of between approximately two centimeters and approximately five centimeters
the angle of curvature of the distal zone (ADZ) is between approximately 30 degrees and approximately 85 degrees;
the angle of curvature of the intermediate zone (AIZ) is between approximately 30 degrees and approximately 60 degrees;
the length of the proximal zone (LPZ) is between approximately eight centimeters and 18 centimeters.
This application is related to copending U.S. patent application Ser. No. 11/609,759, file Dec. 12, 2006, titled “Intrapericardial Delivery Tools and Methods”.
The present invention relates to medical apparatus and methods. More specifically, the present invention relates to tools and methods for intrapericardial subxiphoid access delivery of medical devices and therapy.
Factors (e.g., coronary sinus obstructions, absence of a suitable cardiac vein, high thresholds, or phrenic nerve stimulation) warrant the need for an alternative to a transvenous approach to the implantation of some or all left ventricle (“LV”), left atrial (“LA”), right atrial (“RA”) and right ventricle (“RV”) leads in congestive heart failure (“CHF”) patients in need of cardiac rhythm treatment (“CRT”). Historically, the alternative to a transvenous approach has entailed placement of an epicardial lead, which required invasive surgery and an associated hospital stay.
A minimally invasive pericardial approach to implanting a stimulating lead (e.g., a LV lead) has shown great promise as an alternative to the aforementioned transvenous and invasive surgery methods. In the pericardial approach, an introducer sheath is used to deliver a lead via a subxiphoid access to an implant location within the pericardial space. Visualization techniques, such as traditional fluoroscopy, MRI or endoscopy, are used to guide the introducer sheath to the implantation location within the pericardial space and to guide the final positioning of the lead.
For several reasons, the minimally invasive pericardial approach offers greater simplicity and safety as compared to the transvenous and surgical approaches to stimulation lead implantation. First, the pericardial approach does not require access to the vascular system. Second, it is minimally invasive and does not require surgical intervention and the associated general anesthesia. Third, it allows for a pathway to the entire exterior of the heart (e.g., any chamber, blood vessel or other anatomical feature of the heart) via a single entry point in the patient and in the pericardial sac.
While the pericardial approach allows for a pathway to the entire exterior of the heart, actually accessing the entire exterior of the heart via a delivery tool is another matter. Consequently, there is a need in the art for an introducer sheath that readily facilitates accessing the entire, or nearly the entire, exterior of the heart via a subxiphoid access. There is also a need in the art for a method of delivering a medical device or therapy to any point on the exterior of the heart.
An introducer sheath is disclosed herein. In one embodiment, the sheath includes a tubular body. The tubular body has a proximal zone, an intermediate zone and a distal zone. The proximal zone is generally straight. The intermediate zone extends from a distal end of the proximal zone and curves in a first direction. The distal zone extends from a distal end of the intermediate zone and curves in a second direction different from the first direction.
An introducer sheath is disclosed herein. In one embodiment, the sheath includes a tubular body. The tubular body has a generally straight proximal zone and a curved distal zone. The proximal zone is more rigid than the distal zone.
An introducer is disclosed herein. In one embodiment, the introducer includes inner and outer sheaths coaxial with each other. A distal end of a curved tubular body of the inner sheath extends past a distal end of a curved tubular body of the outer sheath.
FIG. 1 is an overall view of a first embodiment of the introducer sheath and some of its various components.
FIG. 2 is a plan view of the tubular body of the sheath depicted in FIG. 1.
FIGS. 3A-3C illustrate various views of the first embodiment of the tubular body laying next to the left and right ventricle portions of a patient's heart as the tubular body makes an anterior approach to the heart from a subxiphoid opening in the patient's chest wall.
FIGS. 4A-4C illustrate various views of the first embodiment of the tubular body laying next to the left and right ventricle portions of a patient's heart as the tubular body makes a posterior approach to the heart from a subxiphoid opening in the patient's chest wall.
FIG. 5 is a plan view of a tubular body of a sheath similar to that depicted in FIG. 1, except the tubular body has a single curved zone.
FIGS. 6A-6C illustrate various views of the second embodiment of the tubular body laying next to the left and right ventricle portions of a patient's heart as the tubular body makes an anterior approach to the heart from a subxiphoid opening in the patient's chest wall.
FIGS. 7A-7C illustrate various views of the second embodiment of the tubular body laying next to the left and right ventricle portions of a patient's heart as the tubular body makes a posterior approach to the heart from a subxiphoid opening in the patient's chest wall.
FIG. 8 is a cross-sectional elevation taken through the pericardial space when a distal zone of the tubular body has entered the pericardial space.
FIG. 9 is the same view depicted in FIG. 8, except the pericardial space has been expanded via an inflatable balloon.
FIG. 9A is an enlarged cross-section view of the balloon depicted in FIG. 9.
FIG. 10 is a cross-sectional elevation taken through the pericardial space when a distal zone of the tubular body has entered the pericardial space.
FIG. 11 is the same view depicted in FIG. 10, except the tubular body is prevented from being withdrawn from the pericardial space via an expanded inflatable balloon.
FIG. 12 is an end isometric view of the one embodiment of an atraumatic tip.
FIG. 13 is a side view of another embodiment of an atraumatic tip.
FIG. 14 is a side isometric view of the valve by-pass tool employed with the hemostasis valve.
FIG. 15 is an end isometric view of the splittable hemostasis valve.
FIG. 16 is a side isometric view of half of the splittable hemostasis valve after being split.
FIG. 17 is a diagrammatic depiction of the hand control equipped sheath being employed.
FIG. 18 is a diagrammatic depiction of a double sheath introducer being employed.
The present application describes an introducer sheath 10 for delivering a medical device and/or therapy to a pericardial space via a subxiphoid access, wherein the introducer sheath 10 is configured such that it can perform a full 360-degree sweep around the heart. More specifically, a distal zone 45 of the sheath 10 is configured to generally match or conform to the heart epicardial surface as the distal zone 45 performs a full 360-degree sweep (i.e., circumnavigates) about the heart epicardial surface circumference.
The sheath 10 is advantageous in that it facilitates a simple method of accessing the entire or nearly the entire exterior surface of the heart from a subxiphoid access. In other words, the distal zone 45 of the sheath 10 can be swept or made to displace along the exterior surfaces of generally any region of the heart, including the right and left ventricles and right and left atriums, while a proximal zone 35 of the sheath 10 extends through the subxiphoid access.
In sweeping or displacing about the heart, the distal zone 45 of the sheath 10 can move from any side of the heart to any other side of the heart (e.g., from the anterior to the posterior, or vice versa). While the sheath 10 is configured such that the distal zone 45 can sweep a full 360 degrees or more about the surface of the heart, the sheath 10 can be manipulated such that the sweep is less than 360 degrees. For example, a physician could limit the sweep to cover only five, ten or etc. degrees of the heart surface circumference. Ultimately, the sheath distal zone 45 can access any or nearly any region or side of the heart and displace (i.e., sweep) along the heart surface to another region or side of the heart while the proximal sheath zone 35 extends through the subxiphoid access.
For a discussion of a first embodiment of the introducer sheath 10, reference is made to FIG. 1, which is an overall view of the introducer sheath 10 and some of its various components. As shown in FIG. 1, in one embodiment, the introducer sheath 10 includes a tubular body 15, a proximal end 20, a distal end 25, and a hemostasis valve 30 coupled to the proximal end 20.
As illustrated in FIG. 2, which is a plan view of the tubular body 15 of the sheath 10 depicted in FIG. 1, in one embodiment, the tubular body 15 includes a proximal zone 35, an intermediate or transition zone 40, and a distal zone 45. In one embodiment, the tubular body 15 has a diameter of between approximately 7 French and approximately 16 French. In one embodiment, the tubular body 15 will have a diameter that is less than 7 French. In one embodiment, the tubular body 15 will have a diameter of greater than 16 French. In one embodiment, the tubular body will have a diameter of 9 French. In one embodiment, the tubular body 15 will have a wall thickness of between approximately 0.005 inch and approximately 0.025 inch.
As indicated in FIG. 2, in one embodiment, the proximal zone 35 is generally straight and its distal end transitions into the intermediate zone 40, which curves in a first direction. The distal end of the intermediate zone 40 transitions into the distal zone 45, which curves in a second direction reversed to the curve direction of the intermediate zone 40. The combined effect of the curves of the intermediate and distal zones 40, 45 is that the tubular body distal end 25 points in a direction generally parallel to the longitudinal axis of the proximal zone 35. More specifically, in one embodiment, the tubular body distal end 25 ends up pointing in a direction that is anywhere from approximately zero degrees to approximately twenty degrees from being parallel to the longitudinal axis of the proximal zone 35. In one embodiment, the tubular body distal end 25 ends up pointing in a direction that is approximately ten degrees from being parallel to the longitudinal axis of the proximal zone 35.
As shown in FIG. 2, in one embodiment, the proximal zone 35 is generally straight and has a length LPZ of approximately 10 centimeters. In one embodiment, the length LPZ of the proximal zone 35 is between approximately eight centimeters and approximately 18 centimeters.
In one embodiment, the proximal zone 35 is formed of a polymer material such as polyether block amides (“PEBAX”), nylon, polyethylene, or etc. In one embodiment, the proximal zone 35 is formed of a polymer material having a durometer of between approximately 40 Shore D approximately 72 Shore D.
As indicated in FIG. 2, in one embodiment, the intermediate zone 40 is curved in a first direction and has a length LIZ of approximately 2.5 centimeters. In one embodiment, the length LIZ of the intermediate zone 40 is between approximately two centimeters and approximately six centimeters.
In one embodiment, the intermediate zone 40 curves over an angle AIZ of approximately 45 degrees. In one embodiment, the intermediate zone 40 curves over an angle AIZ of between approximately 30 degrees and approximately 60 degrees.
In one embodiment, the intermediate zone 40 curves over a radius RIZ of approximately 2.8 centimeters. In one embodiment, the intermediate zone 40 curves over a radius RIZ of between approximately two centimeters and approximately five centimeters.
In one embodiment, the intermediate zone 40 is formed of a polymer material such as PEBAX, nylon, polyethylene, or etc. In one embodiment, the intermediate zone 40 is formed of a polymer material that is less rigid than the polymer material of the proximal zone 35. In one embodiment, the intermediate zone 40 is formed of a material having a durometer of between approximately 35 Shore D approximately 72 Shore D.
As indicated in FIG. 2, in one embodiment, the distal zone 45 is curved in a second direction that is generally reversed from the direction of the curve of the intermediate zone 40. In one embodiment, the distal zone 45 has a length LDZ of approximately 4.8 centimeters. In one embodiment, the length LDZ of the distal zone 45 is between approximately two centimeters and approximately ten centimeters.
In one embodiment, the distal zone 45 curves over an angle ADZ of approximately 55 degrees. In one embodiment, the distal zone 45 curves over an angle ADZ of between approximately 30 degrees and approximately 85 degrees.
In one embodiment, the distal zone 45 curves over a radius RDZ of approximately 4.6 centimeters. In one embodiment, the distal zone 45 curves over a radius RDZ of between approximately two centimeters and approximately eight centimeters.
In one embodiment, the distal zone 45 is formed of a polymer material such as PEBAX, nylon, polyethylene, or etc. In one embodiment, the distal zone 45 is formed of a polymer material that is less rigid than the polymer material of the intermediate zone 40. In one embodiment, the distal zone 45 is formed of a material having a durometer of between approximately 25 Shore D approximately 72 Shore D.
As indicated in FIG. 2, in one embodiment, the distal end 25 of the tubular body 15 is offset from the distal end of the proximal zone 35 a linear distance D of approximately 6.4 centimeters. In one embodiment, the distal end 25 of the tubular body 15 is offset from the distal end of the proximal zone 35 a linear distance D of between approximately five centimeters and approximately 14 centimeters.
For an illustration of some of the advantages presented by the configuration of the tubular body 15 of the introducer sheath 10 depicted in FIGS. 1 and 2, reference is made to FIGS. 3A-3C and 4A-4C. FIGS. 3A-3C illustrate various views of the first embodiment of the tubular body 15 laying next to the left and right ventricle portions 50, 55 of a patient's heart 60 as the tubular body 15 makes an anterior approach to the heart 60 from a subxiphoid opening 65 in the patient's chest wall 67. FIGS. 4A-4C illustrate various views of the first embodiment of the tubular body 15 laying next to the left and right ventricle portions 50, 55 of a patient's heart 60 as the tubular body 15 makes a posterior approach to the heart 60 from a subxiphoid opening 65 in the patient's chest wall 67.
As can be understood in FIGS. 3A-3C and 4A-4C, in one embodiment, the tubular body 15 enters the subxiphoid opening 65 at a subxiphoid entry angle AE of between approximately 35 degrees and approximately 45 degrees. The curved portions 40, 45 of the tubular body 15 lie next to, and generally match, the heart ventricle surfaces 50, 55. The proximal zone 35 resides in the subxiphoid subcutaneous area, the intermediate zone 40 sits at the pericardial sac opening 70, and the distal zone 45 resides in the pericardial space.
Because of the curved configuration of the tubular body 15 and the differences in rigidity between the various zones 35, 40, 45 of the tubular body 15, the first embodiment of the tubular body 15 is able to sweep 360 degrees around the heart 60 within the pericardial sac. Also, the curved portions 40, 45 can be swept about the heart anterior to posterior, or vice versa. As a result, the first embodiment of the tubular body 15 can be used to deliver a medical device or therapy (e.g., pacing or defibrillation leads, myocardial infarction patches, ablation catheters, mapping catheters, fiber optic video cameras, drugs, etc.) to any location, or nearly any location, on the epicardial surface of the heart, including the right and left ventricle surfaces and the right and left atrium surfaces. Also, the first embodiment of the tubular body 15 can be used to gently loosen pericardial adhesions at any location, or nearly any location, in the pericardial space and prepare the pericardial space for delivery of the medical device and/or therapy. In one embodiment, the curved portions 40, 45 of the tubular body 15 are configured to lie next to, and generally match, the heart ventricle surfaces 50, 55 and/or the heart atrium surfaces 71, 72. In one embodiment, where the curved portions 40, 45 are configured to lie next to, and generally match, both the ventricle and atrium surfaces 50, 55, 71, 72, the curved portions 40, 45 are sufficiently supple to conforming adapt between the ventricle surfaces 50, 55 and the atrium surfaces 71, 72.
The double curve design depicted in FIGS. 1 and 2 can be used to allow some flexibility in medical device placement and maneuverability provided by the sheath 10. If the double curve tubular body 15 is slightly rotated clockwise or counterclockwise, the tubular body distal end 25 and medical device trajectories shift from side to side.
For a discussion of a second embodiment of the introducer sheath 10, reference is made to FIG. 5, which is a plan view of a tubular body 15 of a sheath 10 similar to that depicted in FIG. 1, except the tubular body has a single curved zone. As shown in FIG. 5, in one embodiment, the tubular body 15 includes a proximal zone 35 and a distal zone 45. In one embodiment, the tubular body 15 has a diameter of between approximately 7 French and approximately 16 French. In one embodiment, the tubular body 15 will have a diameter that is less than 7 French. In one embodiment, the tubular body 15 will have a diameter of greater than 16 French. In one embodiment, the tubular body will have a diameter of 9 French. In one embodiment, the tubular body 15 will have a wall thickness of between approximately 0.005 inch and approximately 0.025 inch.
As indicated in FIG. 5, in one embodiment, the proximal zone 35 is generally straight and its distal end transitions into the distal zone 45, which curves in a first direction. Because of the curve of the distal zone 45, the tubular body distal end 25 points in a direction that is anywhere from approximately 20 degrees to approximately 60 degrees from being parallel to the longitudinal axis of the proximal zone 35, as indicated by angle AZ in FIG. 5. In one embodiment, the tubular body distal end 25 ends up pointing in a direction that is approximately 45 degrees from being parallel to the longitudinal axis of the proximal zone 35, as indicated by angle AZ in FIG. 5.
As shown in FIG. 5, in one embodiment, the proximal zone 35 is generally straight and has a length LPZ of approximately 15 centimeters. In one embodiment, the length LPZ of the proximal zone 35 is between approximately eight centimeters and approximately 18 centimeters.
In one embodiment, the proximal zone 35 is formed of a polymer material such as PEBAX, nylon, polyethylene, or etc. In one embodiment, the proximal zone 35 is formed of a polymer material having a durometer of between approximately 40 Shore D approximately 72 Shore D.
As indicated in FIG. 5, in one embodiment, the distal zone 45 is curved in a first direction and has a length LDZ of approximately eight centimeters. In one embodiment, the length LDZ of the distal zone 45 is between approximately seven centimeters and approximately 14 centimeters.
In one embodiment, the distal zone 45 curves over an angle ADZ of approximately 53 degrees. In one embodiment, the distal zone 45 curves over an angle ADZ of between approximately 30 degrees and approximately 60 degrees.
In one embodiment, the distal zone 45 curves over a radius RDZ of approximately seven centimeters. In one embodiment, the distal zone 45 curves over a radius RDZ of between approximately five centimeters and approximately 12 centimeters.
In one embodiment, the distal zone 45 is formed of a polymer material such as PEBAX, nylon, polyethylene, or etc. In one embodiment, the distal zone 45 is formed of a polymer material that is less rigid than the polymer material of the proximal zone 35. In one embodiment, the distal zone 45 is formed of a material having a durometer of between approximately 25 Shore D approximately 72 Shore D.
As indicated in FIG. 5, in one embodiment, the distal end 25 of the tubular body 15 is offset from the distal end of the proximal zone 35 a linear distance D of approximately three centimeters. In one embodiment, the distal end 25 of the tubular body 15 is offset from the distal end of the proximal zone 35 a linear distance D of between approximately two centimeters and approximately five centimeters.
For an illustration of some of the advantages presented by the configuration of the tubular body 15 of the introducer sheath 10 depicted in FIG. 5, reference is made to FIGS. 6A-6C and 7A-7C. FIGS. 6A-6C illustrate various views of the second embodiment of the tubular body 15 laying next to the left and right ventricle portions 50, 55 of a patient's heart 60 as the tubular body 15 makes an anterior approach to the heart 60 from a subxiphoid opening 65 in the patient's chest wall 67. FIGS. 7A-7C illustrate various views of the second embodiment of the tubular body 15 laying next to the left and right ventricle portions 50, 55 of a patient's heart 60 as the tubular body 15 makes a posterior approach to the heart 60 from a subxiphoid opening 65 in the patient's chest wall 67.
As can be understood in FIGS. 6A-6C and 7A-7C, in one embodiment, the tubular body 15 enters the subxiphoid opening 65 at a subxiphoid entry angle AE of between approximately 40 degrees and approximately 50 degrees. The curved portion 45 of the tubular body 15 lies next to, and generally matches, the heart ventricle surfaces 50, 55. The proximal zone 35 resides in the subxiphoid subcutaneous area, the transition point between the proximal and distal zones 35, 45 sits at the pericardial sac opening 70, and the distal zone 45 resides in the pericardial space.
Because of the curved configuration of the tubular body 15 and the differences in rigidity between the zones 35, 45 of the tubular body 15, the second embodiment of the tubular body 15 is able to sweep within the pericardial sac up to approximately 360 degrees around the heart 60 with respect to the pericardial sac entry point and/or the subxiphoid access point. Also, the curved portion 45 can be swept about the heart anterior to posterior, or vice versa. As a result, the second embodiment of the tubular body 15 can be used to deliver a medical device or therapy (e.g., pacing or defibrillation leads, myocardial infarction patches, ablation catheters, mapping catheters, fiber optic video cameras, drugs, etc.) to any location, or nearly any location, on the epicardial surface of the heart, including the right and left ventricle surfaces and the right and left atrium surfaces. Also, the second embodiment of the tubular body 15 can be used to gently loosen pericardial adhesions at any location, or nearly any location, in the pericardial space and prepare the pericardial space for delivery of the medical device and/or therapy. In one embodiment, the curved portion 45 of the tubular body 15 is configured to lie next to, and generally match, the heart ventricle surfaces 50, 55 and/or the heart atrium surfaces 71, 72. In one embodiment, where the curved portion 45 is configured to lie next to, and generally match, both the ventricle and atrium surfaces 50, 55, 71, 72, the curved portion 45 is sufficiently supple to conformingly adapt between the ventricle surfaces 50, 55 and the atrium surfaces 71, 72.
The single curve design depicted in FIG. 5 can be used to allow some flexibility in medical device placement and maneuverability provided by the sheath 10. If the single curve tubular body 15 is slightly rotated clockwise or counterclockwise, the tubular body distal end 25 and medical device trajectories shift from side to side.
To insert the tubular body 15 of the sheath 10 into the pericardial space of the patient, a Touhy needle is used to create entry holes in the high abdominal region near the patient's xiphoid process and in the pericardial sac of the patient. A guidewire is routed through the Touhy needle into the pericardial space and the needle is withdrawn, leaving behind the guidewire to define a pathway to the pericardial space. The straightened out sheath 10 tracks down a guidewire into the pericardial space.
Regardless of whether the first tubular body embodiment (e.g., FIGS. 1 and 2) or the second tubular body embodiment (e.g., FIG. 5) is being employed, the tubular body 15 of the sheath 10 can be straightened to a greater or lesser extent via a straight dilator when the sheath 10 is being inserted into the pericardial space. In one embodiment, the straight dilator is flexible and while the dilator straightens the sheath to some extent, slight curvature still remains in the sheath (i.e., in one embodiment, the flexible dilator is not able completely or fully straighten the sheath).
Once the Touhy needle is withdrawn from the patient, the sheath 10 tracks down a guidewire into the pericardial space. Once inside the pericardial space, the dilator is removed from the sheath 10 and the tubular body 15 is allowed to fully return its curved shape.
Regardless of whether the first tubular body embodiment (e.g., FIGS. 1 and 2) or the second tubular embodiment (e.g., FIG. 5) is being employed, the physician can then rotate and/or push/pull the sheath 10 to direct the distal end of the tubular body 15 to different locations within the pericardial space. Specifically, the physician can rotate and slightly manipulate the proximal end of the sheath extending from the patient to cause the distal end of the sheath to sweep about the heart. In one embodiment, to rotate and otherwise manipulate the proximal end of the sheath, the physician will grasp the hemostasis valve.
For a discussion of a pericardial space expansion feature 80 that may exist on any one or more of the embodiments of the tubular bodies 15 disclosed in this Detailed Description, reference is made to FIGS. 8 and 9. FIG. 8 is a cross-sectional elevation taken through the pericardial space 85 when a distal zone 45 of the tubular body 15 has entered the pericardial space 85. FIG. 9 is the same view depicted in FIG. 8, except the pericardial space 85 has been expanded via an inflatable balloon 80.
As shown in FIG. 8, in one embodiment, a donut-like inflatable balloon 80 is provided near the distal end 25 of the tubular body 15, and the distal zone 45 of the tubular body 15 enters the opening 70 in the pericardial sac 90 in a deflated or unexpanded condition. As indicated in FIG. 9, once the distal zone 45 is securely in the pericardial space 85, the balloon 80 is expanded to separate the pericardial sac 90 from the heart wall 95, thereby increasing the clearance in the pericardial space 85 for the delivery of a medical device (e.g., lead) 100 or therapy.
For a more detailed discussion regarding the configuration of one embodiment of the balloon 80, reference is made to FIG. 9A, which is an enlarged cross-section view of the balloon 80 depicted in FIG. 9. As can be understood from FIG. 9A, when the balloon is inflated, the balloon 80 has a first diameter D of between approximately 0.125 inch and approximately 0.5 inch and a second diameter d of between approximately 0.01 inch and approximately 0.03 inch. When the balloon is un-inflated, the balloon has a first diameter D of between approximately 0.065 inch and approximately 0.09 inch and a second diameter d of between approximately 0.006 inch and approximately 0.02 inch. In one embodiment, the balloon 80 has a material or sheet thickness of between approximately 0.001 inch and approximately 0.01 inch. In one embodiment, the balloon 80 is made of a polymer material such as silicone rubber, isoprene, chronoprene, polyurethane, or etc. In one embodiment, the balloon 80 is placed in fluid communication with a pressurization pump exterior to the patient and sheath 10 via a lumen that extends through the length of the wall of the tubular body 15. The pressurization pump inflates and deflates the balloon 80. Inflating/deflating the balloon can also be accomplished by using a syringe, which is readily available.
For a discussion of an expansion feature 105 for preventing unintentional withdrawal of the tubular body 15 from the pericardial space 85, reference is made to FIGS. 10 and 11. FIG. 10 is a cross-sectional elevation taken through the pericardial space 85 when a distal zone 45 of the tubular body 15 has entered the pericardial space 85. FIG. 11 is the same view depicted in FIG. 10, except the tubular body 15 is prevented from being withdrawn from the pericardial space 85 via an expanded inflatable balloon 105.
As depicted in FIG. 10, a donut-like inflatable balloon 105 is located in the intermediate zone 40 (in the context of the tubular body embodiment depicted in FIGS. 1-2) or at the transition point between the proximal and distal zones 35, 45 (in the context of the tubular body embodiment depicted in FIG. 5). As shown in FIG. 10, the balloon 105 passes through the pericardial sac opening 70 in a deflated condition. The tubular body 15 is positioned such that the deflated balloon 105 resides within the pericardial space 85 adjacent the opening 70 in the pericardial sac 90. Once the tubular body 15 is so positioned, the balloon 105 is inflated to its expanded condition as shown in FIG. 11, thereby preventing the withdrawal of the distal zone 45 of the tubular body 15 from the pericardial space 85.
For a discussion of an atraumatic tip 25 that serves as the distal end 25 of any of the previously described tubular bodies 15, reference is made to FIGS. 12 and 13. FIG. 12 is an end isometric view of the one embodiment of an atraumatic tip 25. FIG. 13 is a side view of another embodiment of an atraumatic tip 25.
As shown in FIGS. 12 and 13, in one embodiment, the atraumatic tip 25 is made from a polymer material that is softer than the polymer material of the distal zone 45. In one embodiment, the atraumatic tip 25 is formed from a polymer material such as silicone rubber, PEBAX, polyethylene, nylon, or etc. In one embodiment, the atraumatic tip 25 has a durometer of approximately 25 Shore D.
As can be understood from FIG. 13, in one embodiment, the atraumatic tip 25 extends approximately 0.5 centimeter past the distal end of the distal zone 45. As can be understood from FIG. 12, in one embodiment, the atraumatic tip 25 includes radiopaque strips 130 that are a polymer material loaded with a radiopaque material (e.g., tungsten, platinum, or etc.) to make the tip visible via fluoroscopy. The atraumatic tip 25 is slightly tapered and has rounded edges to prevent damage to the heart.
For a discussion of a valve by-pass tool 150 and a hemostasis valve 30 for use with any of the previously described tubular bodies 15, reference is made to FIGS. 14-16. FIG. 14 is a side isometric view of the valve by-pass tool 150 employed with the hemostasis valve 30. FIG. 15 is an end isometric view of the splittable hemostasis valve 30. FIG. 16 is a side isometric view of half of the splittable hemostasis valve 30 after being split.
As shown in FIG. 14, the valve by-pass tool 150 is received in the proximal opening of the hemostasis valve 30 and opens up the silicone seal in the valve 30. A medical device (e.g., a lead) can then be inserted through the passage extending through the tool 150 to easily pass through the valve 30 and into the lumen of the tubular body 15. After the distal end of the lead has entered the tubular body 15, the tool 150 can be pulled out of the valve 30 to close the silicone seal about the lead and reduce the amount of fluid (e.g., air) going into or out of the pericardial space. The valve by-pass tool 150 can be reintroduced into the valve 30 as the tubular body 15 is pulled out of the chest cavity and past the proximal connector end of the medical device (e.g., lead).
In one embodiment, the hemostasis valve 30 is removable from the proximal end 20 of the tubular body 15. In one embodiment, as depicted in FIGS. 15 and 16, the hemostasis valve 30 is splittable to facilitate the valve 30 being removed from about a medical device implanted in the patient. In one embodiment, the valve 30 has wings 155 to facilitate its splitting. For greater detail regarding the splittable embodiment of the hemostasis valve 30, see U.S. patent application Ser. No. 11/029,800, which was filed Jan. 4, 2005 and is incorporated into this Detailed Description in its entirety.
In one embodiment, the tubular body 15 has a slick inner surface defining its lumen. The low friction between the lumen of the tubular body 15 facilitates the easy, non-binding passage of a medical device through the tubular body 15.
In one embodiment, the distal end 25 of the tubular body 15 includes a fiber optic camera. The camera allows for the visualization of the lead placement location and to avoid coronary arteries, fat or other obstacles within the pericardial space.
In one embodiment, the tubular body 15 is peelable or splittable as disclosed in PCT Applications 2006/016373 and 2006/016372, both of which are hereby incorporated into this Detailed Description in their entireties, and claim the benefit of U.S. Provisional Patent Applications 60/675,973 and 60/677,423, respectively.
After a lead or other type of medical device is implanted in the pericardial space, the sheath 10 is gently pulled back until it exits the pericardial sac and the skin just below the coastal margin. The sheath 10 and hemostasis valve 30 can then be split to allow their removal from about the lead. Alternatively, the sheath 10 and hemostasis valve 30 can be removed in one piece by using the valve by-pass tool 150 to allow the lead suture sleeve and lead connector to pass through the valve 30.
For a discussion of a sheath 10 having a deflection hand control 180, reference is made to FIG. 17, which is a diagrammatic depiction of the hand control equipped sheath being employed. In one embodiment, the hand control 180 simply provides a gripping surface for the physician to grasp the sheath 10 and torque, push and pull the sheath 10.
In one embodiment, the handle 180 is coupled to deflection wires 181 longitudinally extending through the walls of the tubular body 15. Manipulating the handle 180 displaces the wires 181 within the walls and deflects the distal end of the tubular body. In one embodiment, the handle 180 serves to manipulate an inner and/or outer tubular body as provided for in the following discussion regarding a sheath-in-sheath introducer.
For a discussion of a sheath-in-sheath introducer 200, reference is made to FIG. 18, which is a diagrammatic depiction of the introducer 200 being employed. As shown in FIG. 18, in one embodiment, the introducer 200 includes two sheaths 205, 210, each sheath employing a curved tubular body 215, 220. The internal tubular body 220 is longer and softer than the outer tubular body 215.
A dilator is inserted in the tubular body 215 of the outer sheath 205, which is then inserted through the subxiphoid and pericardial sac openings 65, 70. Once the distal end of the tubular body 215 of the outer sheath 205 is in the pericardial space 85, the dilator is withdrawn from the outer tubular body 215. The tubular body 220 of the inner sheath 210 is then inserted into the tubular body 215 of the outer sheath 205 such that the inner tubular body 220 protrudes from the outer tubular body 215 inside the pericardial space 85.
As previously mentioned, both tubular bodies 215, 220 are curved and the inner tubular body 220 is longer and softer than the outer tubular body 215. Consequently, rotating the tubular bodies 215, 220 relative to each other and/or longitudinally extending or retracting the tubular bodies 215, 220 relative to each other changes the overall shape and orientation of the introducer 200.
In one embodiment, one or both of the sheaths 205, 210 will employ double or single curved tubular bodies as discussed with respect to FIGS. 1, 2 and 5. In one embodiment, the tubular bodies 205, 210 will have generally rigid proximal zones and softer curved distal zones, as discussed with respect to FIGS. 1, 2 and 5.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3896804 *Nov 13, 1973Jul 29, 1975Astra Sjuco AbCatheter for submucous administration of local anesthetics in obtaining paracervical blockUS3952742 *Jun 12, 1974Apr 27, 1976Taylor Duane FNeedle-carried, transthoracic, cannula-type cardiac resuscitation instrumentUS4865037Nov 13, 1987Sep 12, 1989Thomas J. FogartyMethod for implanting automatic implantable defibrillatorUS4991578Apr 4, 1989Feb 12, 1991Siemens-Pacesetter, Inc.Method and system for implanting self-anchoring epicardial defibrillation electrodesUS4998975Oct 30, 1989Mar 12, 1991Siemens-Pacesetter, Inc.Travenously placed defibrillation leadsUS5188605 *May 8, 1991Feb 23, 1993Cordis CorporationSeparable insertion toolUS5215540 *Jan 31, 1992Jun 1, 1993St. Jude Medical, Inc.Right coronary catheterUS5312355 *Jun 26, 1992May 17, 1994H L Medical Inventions, Inc.Splittable hemostatic valve and sheath and the method for using the sameUS5336252Jun 22, 1992Aug 9, 1994Cohen Donald MSystem and method for implanting cardiac electrical leadsUS5571161Apr 12, 1995Nov 5, 1996Starksen; Niel F.Apparatus and method for implanting electrical leads in the heartUS5634895Jun 7, 1995Jun 3, 1997Cormedics Corp.Apparatus and method for transpericardial delivery of fluidUS5653730 *Sep 28, 1994Aug 5, 1997Hemodynamics, Inc.Surface opening adhesive sealerUS5716392Jan 5, 1996Feb 10, 1998Medtronic, Inc.Minimally invasive medical electrical leadUS5840059Jun 7, 1995Nov 24, 1998Cardiogenesis CorporationTherapeutic and diagnostic agent deliveryUS5902289 *Oct 14, 1997May 11, 1999Daig CorporationPrecurved guiding introducer system for treatment of atrial arrhythmiaUS5997525Jun 29, 1998Dec 7, 1999Cardiogenesis CorporationTherapeutic and diagnostic agent deliveryUS6117105 *Dec 4, 1998Sep 12, 2000Cardeon CorporationAortic catheter and methods for inducing cardioplegic arrest and for selective aortic perfusionUS6132417 *Aug 19, 1998Oct 17, 2000Scheider/NamicRight coronary artery catheterUS6224584May 4, 1999May 1, 2001Eclipse Surgical Technologies, Inc.Therapeutic and diagnostic agent deliveryUS6423051Sep 16, 1999Jul 23, 2002Aaron V. KaplanMethods and apparatus for pericardial accessUS6524298Feb 27, 2001Feb 25, 2003Cardiogenesis CorporationTherapeutic and diagnostic agent deliveryUS6638268 *Apr 6, 2001Oct 28, 2003Imran K. NiaziCatheter to cannulate the coronary sinusUS6659950Apr 12, 2001Dec 9, 2003Syde TaheriPercutaneous epicardial injectionUS6718212Oct 12, 2001Apr 6, 2004Medtronic, Inc.Implantable medical electrical lead with light-activated adhesive fixationUS7288096Feb 18, 2003Oct 30, 2007Origin Medsystems, Inc.Apparatus for placement of cardiac defibrillator and pacerUS7398781Aug 9, 2000Jul 15, 2008Maquet Cardiovascular, LlcMethod for subxiphoid endoscopic accessUS7526342Oct 29, 2003Apr 28, 2009Maquet Cardiovascular LlcApparatus for endoscopic cardiac mapping and lead placementUS7621904 *Oct 21, 2004Nov 24, 2009Boston Scientific Scimed, Inc.Catheter with a pre-shaped distal tipUS20020072737Apr 17, 2001Jun 13, 2002Medtronic, Inc.System and method for placing a medical electrical leadUS20020151868Apr 12, 2001Oct 17, 2002Syde TaheriPercutaneous epicardial injectionUS20030074041Oct 12, 2001Apr 17, 2003Parry Andrew J.Implantable medical electrical lead with light-activated adhesive fixationUS20030208141 *May 6, 2002Nov 6, 2003Worley Seth J.Introducer for accessing the coronary sinus of a heartUS20030212446May 10, 2002Nov 13, 2003Kaplan Aaron V.Methods and apparatus for lead placement on a surface of the heartUS20040102804Jan 17, 2003May 27, 2004Chin Albert K.Apparatus and methods for endoscopic surgical proceduresUS20040216748Jul 10, 2003Nov 4, 2004Chin Albert K.Apparatus and method for endoscopic encirclement of pulmonary veins for epicardial ablationUS20050102003Oct 23, 2003May 12, 2005Grabek James R.Perficardial pacing lead placement device and methodUS20050154376Nov 5, 2004Jul 14, 2005Riviere Cameron N.Robot for minimally invasive interventionsUS20060106442May 19, 2005May 18, 2006The Board Of Trustees Of The Leland Stanford Junior UniversityDevices and methods for treating cardiac pathologiesUS20060116746Jan 5, 2006Jun 1, 2006Chin Albert KCardiac electrode attachment procedureWO1997025099A1Dec 30, 1996Jul 17, 1997Medtronic, Inc.Minimally invasive medical electrical leadWO2004002288A2May 9, 2003Jan 8, 2004Cerebral Vascular Applications, Inc.Methods and apparatus for lead placement on a surface of the heartWO2005046461A1Nov 5, 2004May 26, 2005Carnegie Mellon UniversityRobot for minimally invasive interventions* Cited by examinerNon-Patent CitationsReference1Final Office Action, mailed Jul. 6, 2010-Related U.S. Appl. No. 11/609,759.2Final Office Action, mailed Jul. 6, 2010—Related U.S. Appl. No. 11/609,759.3NonFinal Office Action, mailed Feb. 4, 2010-Related U.S. Appl. No. 11/609,759.4NonFinal Office Action, mailed Feb. 4, 2010—Related U.S. Appl. No. 11/609,759.5NonFinal Office Action, mailed Jul. 6, 2009: Related U.S. Appl. No. 11/609,759.Referenced byCiting PatentFiling datePublication dateApplicantTitleUS9095364 *Jul 18, 2012Aug 4, 2015Acclarent, Inc.Device and method for dilating an airway stenosisUS9095646 *Jul 16, 2012Aug 4, 2015Acclarent, Inc.Devices and methods for transnasal dilation and irrigation of the sinusesUS9339292Mar 13, 2013May 17, 2016Pacesetter, Inc.Medical device for accessing space along an interior surface of an anatomic layerUS20130184568 *Jul 18, 2012Jul 18, 2013Ketan P. MuniDevice and method for dilating an airway stenosisUS20130184683 *Jul 16, 2012Jul 18, 2013Mina W.B. ChowDevices and methods for transnasal dilation and irrigation of the sinusesUS20140018732 *Jan 4, 2012Jan 16, 2014Spotlight Technology Partners LlcApparatus and Methods for Accessing and Treating a Body Cavity, Lumen, or OstiumUS20160001045 *Sep 11, 2015Jan 7, 2016W. L. Gore & Associates, Inc.Dilator systems and methods* Cited by examinerClassifications U.S. Classification604/532, 604/96.01, 604/264, 604/525International ClassificationA61M25/00Cooperative ClassificationA61M25/0041, A61M25/0054, A61M25/0147, A61M25/0662, A61M25/1002European ClassificationA61M25/06H, A61M25/00R2Legal EventsDateCodeEventDescriptionDec 12, 2006ASAssignmentOwner name: PACESETTER, INC., CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KAMPA, GREG;BARLOW, ANNA;MORGAN, KEVIN L.;AND OTHERS;SIGNING DATES FROM 20061207 TO 20061212;REEL/FRAME:018621/0753Apr 15, 2015FPAYFee paymentYear of fee payment: 4Apr 15, 2015SULPSurcharge for late paymentRotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services